Megprate 133.5mg/58mg Tablet CR

Overview Megprate 133.5mg/58mg Tablet CR

Epilepticare CR 133.5mg/58mg tablets combine two medications to manage epilepsy, a neurological condition marked by recurring seizures. This dual-action formulation regulates aberrant brain activity, promoting nerve relaxation and seizure prevention. Epilepticare CR should be taken with meals. Dosage, determined by your physician, may be gradually increased until your seizures are controlled. Therapeutic effects may take weeks; consistent use is crucial. Discontinuation, except under medical supervision, risks increased seizure frequency and potential exacerbation of bipolar disorder (if applicable). Common side effects include nausea and tremors; others, such as vomiting, headache, liver complications, and upper abdominal discomfort, are possible. While most side effects resolve, persistent or bothersome symptoms warrant medical attention. Strategies to mitigate side effects may be available. Prior to commencing treatment, inform your doctor of any kidney or liver disease, meningitis, depression, or suicidal ideation. Disclosure of all other medications, including contraceptives, is essential due to potential drug interactions. During pregnancy or breastfeeding, use is conditional on necessity, with potential dosage adjustments. Avoid driving or cycling if drowsiness or dizziness occurs. Regular blood tests may be required to monitor treatment efficacy. Alcohol consumption should be avoided as it may intensify side effects. Weight gain is a potential consequence; a balanced diet, limiting high-calorie snacks, and regular exercise are recommended. Report any unusual mood changes, new or worsening depression, or suicidal thoughts or behaviors to your doctor immediately.

Primary Ingredients of Megprate 133.5mg/58mg Tablet CR

No text provided to rephrase.

Uses of Megprate 133.5mg/58mg Tablet CR

Seizure disorder

Major Benefits of Megprate 133.5mg/58mg Tablet CR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Megprate 133.5mg/58mg Tablet CR whole; avoid crushing, chewing, or breaking it. Administer this medicine with food.

Common Side effects of Megprate 133.5mg/58mg Tablet CR:

• Nausea
• Tremors

How to use Megprate 133.5mg/58mg Tablet CR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Megprate 133.5mg/58mg Controlled-Release tablet with food.

How Megprate 133.5mg/58mg Tablet CR works:

The extended-release tablet, Megprate CR, contains 133.5mg of sodium valproate and 58mg of valproic acid, both anticonvulsant agents.

What if you forget to take Megprate 133.5mg/58mg Tablet CR :

Should you forget to take a Megprate 133.5mg/58mg CR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.